Effects of TBE VS GE on Scapular Dyskinesia in Male Cricketers.

January 22, 2025 updated by: Riphah International University

Effects of Theraband Versus General Exercises on Scapular Dyskinesia in Male Cricketers.

We wanted to find the effectiveness between the theraband and general exercises on scapular dyskinesis in male cricket players.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Cricket game is considered a non-contact low-injury risk sport associated to other sports, chronic and acute traumatic injuries are the two common types of injury mechanisms. Theraband exercises are those exercises which are considered as a safe tool which increases the functional ability and muscle strength. Scapular dyskinesis (which is called as sick scapula) as commonly defined as an alteration or deviation in the resting position or during movable position of the scapula during shoulder joint motions. A study reported that Theraband exercises increase the function of the muscles. These muscles participate to the strength of the shoulder girdle, stability and mobility. Theraband exercises are considered to be able increase the proprioception and balance. The prevalence of scapular dyskinesia (74.6%) dominant side scapula turns medially, inferiorly, and also tilts anteriorly as relate to non-dominant side shoulder blade.Scapular dyskinesia has been more determined in healthy individuals but statics has also mentioned that scapular dyskinesia a greater prevalence in overhead (61%) than non-overhead sportspersons (33%). Maximum cricket players complain that they feel discomfort in the scapular region. Because occasionally the scapular dyskinesia causes the discomfort in scapula region and it is due to the muscles weakness of the scapula. It is mostly occur in overhead athletes because of the constant repetitions of the shoulder movement over the head. For intervention purpose in scapular dyskinesia, cricket players maximum concentrate on general exercises instead of theraband exercises because they don't aware about the effectiveness of theraband exercises in this condition and theraband exercises involve using resistance bands of varying strengths to perform specific movements targeting the muscles around the scapula. These exercises could help improve the muscle strength, endurance, and control, which will be essential for stabilizing the scapula and improving its movement patterns while general exercises improve the overall functional movement patterns, which may indirectly benefit scapular dyskinesia by strengthening surrounding muscles and improving overall shoulder mechanics. Despite up to my searched no study has been found about it so this study is designed to find the effectiveness of thera-band exercises on scapular dyskinesia in male cricketers.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
52

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Pakistan
    • Khyber Pkhtunkhwa
      • Peshawar, Khyber Pkhtunkhwa, Pakistan, 25000
        • JI youth cricket academy, peshawar
        • Contact:
        • Principal Investigator:
          • Nadia Ishtiaq, MS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • • Scapular dyskinesia type I

    • Only male cricketers.
    • Age from 18 to 30 years old.
    • Training at least 4 times per week and 10 hours weekly training.
    • Male cricket players playing since last one year.

Exclusion Criteria:

  • • The history of scapular fracture repair surgery and neck surgery during previous 12 months.

    • The players that are out of practice from 5 weeks.
    • Traumatic history of cervical region and scapula.
    • Serious pathologies regarding shoulder, cervical and scapula.
    • Female cricketers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: General exercises
Resistance based exercises with load for muscles strengthing.
Other: General exercises
4 general exercises were done by control group with 10 repetitions and 3 sets, 6 times per week, up to 8 weeks.These exercises are for lower trapzius and serratus anterior mucles strengthing.
Experimental: Theraband exercises
Rubber based resistance exercises which target the specific muscles for strength.
Other: Theraband exerises
5 Thera-band exercises were completed by experimental group with 3 sets and 10 repetitions, 6 times per week, up to 8 weeks. These exercises are for lower trapzius and serratus anterior mucles strengthing.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Hand-held dynamometer
Time Frame: 8 week
Handheld Dynamometry (HHD) is a procedure utilized to judge muscle strength. This version of a dynamometer is set up or held by the physical therapist to originate an objective measurement of force. The Scapular protraction test is usually used to measure the strength of the serratus anterior while Prone Scapular Retraction test is utilized to evaluate the strength of lower trapezius muscle then utilized a dynamometer to measure the force applied by the participant. A perfect reading on the dynamometer, with small asymmetry between sides, pretends normal serratus anterior function otherwise it will be abnormal.
8 week

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Numeric pain rating scale
Time Frame: 8 week
The Numeric Pain Rating Scale, which is utilized in medical settings, permits persons to rate their pain on a scale from 0 to 10, with 0 representing that there is no pain and 10 showing the worst possible pain. The pain severity is evaluated by this scale
8 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Riphah International University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nadia Ishtiaq, MS, nadia.ishtiaq@riphah.edu.pk

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 1, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 3, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 5, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 22, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 22, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 25, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 22, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • RiphahIU/ m66icc nadia ishtiaq

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings